New cancer drug enters human testing for advanced tumors
NCT ID NCT06736327
Summary
This is the first human study of an experimental cancer drug called SKB500. Researchers want to find out if it's safe, how the body processes it, and if it shows any signs of fighting cancer. The study will enroll 180 adults with advanced solid tumors that haven't responded to standard treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
JILIN Cancer Hospital
RECRUITINGJilin, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.